Clinical Trial Update: Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates risk-adapted omission of Level Va irradiation in nasopharyngeal carcinoma, with the study currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Nasopharyngeal Carcinoma by AJCC V9 Stage | Phase 3 | Status: NOT_YET_RECRUITING